Deficits in visceral pain and hyperalgesia of mice with a disruption of the tachykinin NK1 receptor gene
暂无分享,去创建一个
C. Roza | S. P. Hunt | S. Hunt | F. Cerveró | J. Laird | J.M.A. Laird | T. Olivar | C. De Felipe | F. Cervero | C. Felipe | T. Olivar | C. Roza | S. P. Hunt | Jennifer M. A. Laird | Fernando Cervero
[1] A. Saria,et al. Evans blue fluorescence: quantitative and morphological evaluation of vascular permeability in animal tissues , 1983, Journal of Neuroscience Methods.
[2] S. Boyce,et al. Enantioselective inhibition of the formalin paw late phase by the NK1 receptor antagonist L-733,060 in gerbils , 1996, PAIN.
[3] A. Stabentheiner,et al. Participation of nitric oxide in the mustard oil-induced neurogenic inflammation of the rat paw skin. , 1993, European journal of pharmacology.
[4] A. Dickenson,et al. The effect of intrathecal administration of RP67580, a potent neurokinin 1 antagonist on nociceptive transmission in the rat spinal cord , 1993, Neuroscience Letters.
[5] S. Harrison,et al. Non-specific effects of the tachykinin NK1 receptor antagonist, CP-99,994, in antinociceptive tests in rat, mouse and gerbil. , 1994, European journal of pharmacology.
[6] M. Millan,et al. Antinociceptive profiles of non-peptidergic neurokinin1 and neurokinin2 receptor antagonists: a comparison to other classes of antinociceptive agent , 1995, Pain.
[7] P. Mantyh,et al. Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor. , 1997, Science.
[8] S. Hunt,et al. Comparison of cardiorespiratory reflexes in NK1 receptor knockout, heterozygous and wild-type mice in vivo. , 1998, Journal of the autonomic nervous system.
[9] C. Gardner,et al. The NK1 antagonist GR203040 inhibits cyclophosphamide-induced damage in the rat and ferret bladder. , 1997, General pharmacology.
[10] K. McCarson,et al. Central and peripheral expression of neurokinin-1 and neurokinin-3 receptor and substance P-encoding messenger RNAs: peripheral regulation during formalin-induced inflammation and lack of neurokinin receptor expression in primary afferent sensory neurons , 1999, Neuroscience.
[11] H. Schaible,et al. Involvement of substance P and neurokinin-1 receptors in the hyperexcitability of dorsal horn neurons during development of acute arthritis in rat's knee joint. , 1995, Journal of neurophysiology.
[12] L. Buéno,et al. Involvement of neurokinin 1 and 2 receptors in viscerosensitive response to rectal distension in rats. , 1994, Gastroenterology.
[13] C. Epstein,et al. Primary afferent tachykinins are required to experience moderate to intense pain , 1998, Nature.
[14] M. Palkovits,et al. Hypoalgesia in mice with a targeted deletion of the tachykinin 1 gene. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[15] F. Cerveró. Sensory innervation of the viscera: peripheral basis of visceral pain. , 1994, Physiological reviews.
[16] J. Longhurst,et al. Role of spinal NK1 receptors in cardiovascular responses to chemical stimulation of the gallbladder. , 1995, The American journal of physiology.
[17] J. Laird,et al. Cyclophosphamide cystitis in mice: Behavioural characterisation and correlation with bladder inflammation , 1999, European journal of pain.
[18] J. Besson,et al. Spinal Substance P Receptor Expression and Internalization in Acute, Short-Term, and Long-Term Inflammatory Pain States , 1999, The Journal of Neuroscience.
[19] R. Traub. The spinal contribution of substance P to the generation and maintenance of inflammatory hyperalgesia in the rat , 1996, PAIN.
[20] W. Willis,et al. Neurokinin 1 and 2 antagonists attenuate the responses and NK1 antagonists prevent the sensitization of primate spinothalamic tract neurons after intradermal capsaicin. , 1994, Journal of neurophysiology.
[21] S. Lawson,et al. Differences in expression of oligosaccharides, neuropeptides, carbonic anhydrase and neurofilament in rat primary afferent neurons retrogradely labelled via skin, muscle or visceral nerves , 1998, Neuroscience.
[22] A. Basbaum,et al. Morphological characterization of substance P receptor‐immunoreactive neurons in the rat spinal cord and trigeminal nucleus caudalis , 1995, The Journal of comparative neurology.
[23] T. Ness,et al. Colorectal distension as a noxious visceral stimulus: physiologic and pharmacologic characterization of pseudaffective reflexes in the rat , 1988, Brain Research.
[24] P. Laduron,et al. Pharmacological properties of a potent and selective nonpeptide substance P antagonist. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[25] W. Jänig,et al. Afferent and sympathetic neurons projecting into lumbar visceral nerves of the male rat , 1991, The Journal of comparative neurology.
[26] C. Maggi,et al. The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles , 1998, Neuropeptides.
[27] P. Mantyh,et al. Transmission of chronic nociception by spinal neurons expressing the substance P receptor. , 1999, Science.
[28] K. Westlund,et al. Differential roles of neurokinin 1 and neurokinin 2 receptors in the development and maintenance of heat hyperalgesia induced by acute inflammation , 1997, British journal of pharmacology.
[29] Q. Ma,et al. Involvement of neurokinin receptors in the induction but not the maintenance of mechanical allodynia in rat flexor motoneurones. , 1995, The Journal of physiology.
[30] P. Mclean,et al. Effects of tachykinin receptor antagonists on the rat jejunal distension pain response. , 1998, European journal of pharmacology.
[31] P. Rivière,et al. Effect of fedotozine on the cardiovascular pain reflex induced by distension of the irritated colon in the anesthetized rat. , 1994, European journal of pharmacology.
[32] C. Maggi,et al. NK-1, but not NK-2, tachykinin receptors mediate plasma extravasation induced by antidromic C-fiber stimulation in rat hindpaw: Demonstrated with the NK-1 antagonist CP-96,345 and the NK-2 antagonist Men 10207 , 1992, Neuroscience Letters.
[33] M. Maccoss,et al. In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonists. , 1997, European journal of pharmacology.
[34] James N. Campbell,et al. Peripheral and central mechanisms of cutaneous hyperalgesia , 1992, Progress in Neurobiology.
[35] E. Torebjörk,et al. Novel classes of responsive and unresponsive C nociceptors in human skin , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[36] T. Doubell,et al. Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons , 1996, Nature.
[37] S. Raja,et al. Neurokinin-1 receptors are involved in behavioral responses to high-intensity heat stimuli and capsaicin-induced hyperalgesia in mice. , 1999, Anesthesiology.
[38] C. Maggi,et al. Cyclophosphamide cystitis in rats: involvement of capsaicin-sensitive primary afferents. , 1992, Journal of the autonomic nervous system.
[39] C. Woolf,et al. Tachykinin NK1 receptor antagonist RP67580 attenuates progressive hypersensitivity of flexor reflex during experimental inflammation in rats. , 1997, European journal of pharmacology.
[40] M. Giamberardino,et al. Artificial ureteral calculosis in rats: behavioural characterization of visceral pain episodes and their relationship with referred lumbar muscle hyperalgesia , 1995, Pain.
[41] Stephen P. Hunt,et al. Altered nociception, analgesia and aggression in mice lacking the receptor for substance P , 1998, Nature.